Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,670
Closed -$347K 451
2024
Q2
$347K Buy
4,670
+258
+6% +$19.3K ﹤0.01% 356
2024
Q1
$344K Buy
+4,412
New +$328K ﹤0.01% 372
2021
Q4
Sell
-3,610
Closed -$266K 433
2021
Q3
$266K Sell
3,610
-3,639
-50% -$273K ﹤0.01% 384
2021
Q2
$484K Sell
7,249
-1,537
-17% -$103K ﹤0.01% 324
2021
Q1
$654K Sell
8,786
-1,800
-17% -$137K ﹤0.01% 304
2020
Q4
$771K Sell
10,586
-1,334
-11% -$94.2K 0.01% 276
2020
Q3
$792K Buy
+11,920
New +$754K 0.01% 256
2018
Q1
Sell
-58,400
Closed -$2.5M 410
2017
Q4
$2.5M Buy
+58,400
New +$2.33M 0.04% 114

Other funds holding HOLX

Banco Santander's HOLX Position: Q3 2024 in Review

Banco Santander sold out of Hologic (HOLX) in Q3 2024, closing a stake of 4,670 shares — an estimated $347K sold.

Banco Santander first reported a position in HOLX in Q4 2017 and held it in 8 quarters. The position peaked at $2.5M in Q4 2017. 727 funds tracked by Wall St. Rank hold HOLX as of Q3 2024.

  • Banco Santander reported no remaining Hologic position as of Q3 2024 after selling out during the quarter.
  • Banco Santander sold 4,670 Hologic shares in Q3 2024, an estimated $347K.
  • Banco Santander first reported a position in Hologic in Q4 2017 and held it in 8 quarters.
  • Banco Santander's Hologic position peaked at $2.5M in Q4 2017.
  • 727 funds tracked by Wall St. Rank held Hologic as of Q3 2024.

Based on Banco Santander's 13F filing for Q3 2024, filed 12 Nov 2024.